Olaguoke Akinwande
Olaguoke Akinwande has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Raja Siva Ramaswamy
Mallinckrodt Institute of Radiology, Washington University School of Medicine in St. Louis, 510 South Kingshighway Boulevard, CB 8131, St. Louis, MO 63139
2 shared publications - Aamir Ahmad
Hamad Medical Corporation, Doha 3050, Qatar
1 shared publication Abdulrahman Masrani
Division of Interventional Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
1 shared publication- Carlos J. Guevara
Department of Diagnostic and Interventional Radiology, University of Texas Health Center, Houston, Texas, USA
1 shared publication Charles Scoggins
University of Louisville
1 shared publicationChristopher Hiro Noda
Division of Interventional Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
1 shared publication
Latest Publications
- 8 June 2019
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 39 (6) , 3071-3077
Comparison of Response and Outcomes of Drug-eluting Bead Chemoembolization (DEB-TACE) Versus Radioembolization (TARE) for Patients With Colorectal Cancer Liver Metastases
Background: To compare outcomes for patients with colorectal cancer liver metastases (CRCLM) treated by drug-eluting bead chemoembolization (DEB-TACE) or radioembolization (TARE). Patients and Methods: A single-center retrospective review was carried out on 202 patients with CRCLM, treated by DEB-TACE (n=47) or TARE (n=155) patients. Propensity-matching yielded 44 pairs. Paired statistical analysis was performed on matched pair demographics, treatment response, and survival. Results: Patients treated with DEB-TACE had worse extra-hepatic metastasis (68.1 vs. 47.7%, p=0.014) and ≥10 liver lesions (42.2 vs. 68.8%, p=0.001). Matched patients treated with DEB-TACE had a trend towards worse toxicity (27% vs. 9.1% (p=0.057). Index DEB-TACE treatment was not a prognostic factor for overall survival (hazard ratio=0.94, 95% confidence intervaI=0.54-1.65; p=0.83). Conclusion: In the matched CRCLM cohort, there was a trend towards worse toxicity post-DEB-TACE treatment, but it was not an independent prognostic factor for survival.
- 8 June 2019
- Published by International Institute of Anticancer Research in Anticancer Research
- Vol. 39 (6) , 3071-3077
Comparison of Response and Outcomes of Drug-eluting Bead Chemoembolization (DEB-TACE) Versus Radioembolization (TARE) for Patients With Colorectal Cancer Liver Metastases
Background: To compare outcomes for patients with colorectal cancer liver metastases (CRCLM) treated by drug-eluting bead chemoembolization (DEB-TACE) or radioembolization (TARE). Patients and Methods: A single-center retrospective review was carried out on 202 patients with CRCLM, treated by DEB-TACE (n=47) or TARE (n=155) patients. Propensity-matching yielded 44 pairs. Paired statistical analysis was performed on matched pair demographics, treatment response, and survival. Results: Patients treated with DEB-TACE had worse extra-hepatic metastasis (68.1 vs. 47.7%, p=0.014) and ≥10 liver lesions (42.2 vs. 68.8%, p=0.001). Matched patients treated with DEB-TACE had a trend towards worse toxicity (27% vs. 9.1% (p=0.057). Index DEB-TACE treatment was not a prognostic factor for overall survival (hazard ratio=0.94, 95% confidence intervaI=0.54-1.65; p=0.83). Conclusion: In the matched CRCLM cohort, there was a trend towards worse toxicity post-DEB-TACE treatment, but it was not an independent prognostic factor for survival.
- 16 May 2019
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 25 (3) , 225-230
Cryoablation of low-flow vascular malformations
Diagnostic and Interventional Radiology
- 16 May 2019
- Published by Galenos Yayinevi in Diagnostic and Interventional Radiology
- Vol. 25 (3) , 225-230
Cryoablation of low-flow vascular malformations
Diagnostic and Interventional Radiology
- 1 March 2019
- Published by Elsevier in Clinical Imaging
- Vol. 54, 12-14
Embolization of a congenital arteriovenous malformation arising off the internal mammary artery
- 1 March 2019
- Published by Elsevier in Clinical Imaging
- Vol. 54, 12-14
Embolization of a congenital arteriovenous malformation arising off the internal mammary artery
- 1 September 2017
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 01 (03) , 225-232
Future Interventional Oncology Catheter-Based Therapies
Minimally invasive techniques in the treatment of cancer continue to develop at a rapid pace. Although surgical resection currently remains the only option for a complete cure, not all diseases are amenable to complete removal. This leaves opportunities to develop effective downstaging techniques as well as palliative care. In the realm of minimally invasive oncologic techniques, catheter-based therapies are an attractive option because malignancies require a blood supply to remain active. The intra-arterial (IA) delivery of specific tumoricidal drugs has been shown to be a successful delivery method in a variety of different cancers, and it is currently a progressive area of research. There is work both to increase the delivery specificity of oncologic drugs, including SW43 sigma receptor ligand and nanoparticle research. In addition, oncolytic viral therapy and 3-bromopyruvate have become increasingly more attractive tumoricidal drug prospects. In the future, the success of these therapies will ultimately determine the degree to which IA delivery will compete with the systemic delivery of drugs in the treatment of cancer.
- 1 September 2017
- Published by Georg Thieme Verlag KG in Digestive Disease Interventions
- Vol. 01 (03) , 225-232
Future Interventional Oncology Catheter-Based Therapies
Minimally invasive techniques in the treatment of cancer continue to develop at a rapid pace. Although surgical resection currently remains the only option for a complete cure, not all diseases are amenable to complete removal. This leaves opportunities to develop effective downstaging techniques as well as palliative care. In the realm of minimally invasive oncologic techniques, catheter-based therapies are an attractive option because malignancies require a blood supply to remain active. The intra-arterial (IA) delivery of specific tumoricidal drugs has been shown to be a successful delivery method in a variety of different cancers, and it is currently a progressive area of research. There is work both to increase the delivery specificity of oncologic drugs, including SW43 sigma receptor ligand and nanoparticle research. In addition, oncolytic viral therapy and 3-bromopyruvate have become increasingly more attractive tumoricidal drug prospects. In the future, the success of these therapies will ultimately determine the degree to which IA delivery will compete with the systemic delivery of drugs in the treatment of cancer.
- 20 September 2016
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 40 (2) , 315-317
Hepatic Arterial Therapy for First-Line Treatment of Unresectable Colorectal Liver Metastases: What We Know in the Wake of Two Recent Randomized Control Trials
- 20 September 2016
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 40 (2) , 315-317
Hepatic Arterial Therapy for First-Line Treatment of Unresectable Colorectal Liver Metastases: What We Know in the Wake of Two Recent Randomized Control Trials
- 1 April 2015
- Published by SAGE Publications in Acta Radiologica
- Vol. 56 (4) , 419-427
Review of pelvic collateral pathways in aorto-iliac occlusive disease: demonstration by CT angiography
The pelvic collateral system is a robust network of communicating vessels that provide the functional reserve to withstand chronic aorto-iliac occlusive disease. For establishment of collateral circulation, the afferent vessel must originate proximal to the occlusion and anastomose with vessel/s distal to the occlusion. These collateral pathways can be classified as viscero–systemic, systemic–systemic, and visceral–visceral. CT angiography (CTA) is often the initial modality for evaluating patients with atherosclerotic vascular disease, because it is non-invasive and has been shown to be comparable to conventional angiography. Most collateral pathways are well demonstrated on CTA, which therefore is a useful tool for preoperative planning and regional interventional procedures.
- 1 April 2015
- Published by SAGE Publications in Acta Radiologica
- Vol. 56 (4) , 419-427
Review of pelvic collateral pathways in aorto-iliac occlusive disease: demonstration by CT angiography
The pelvic collateral system is a robust network of communicating vessels that provide the functional reserve to withstand chronic aorto-iliac occlusive disease. For establishment of collateral circulation, the afferent vessel must originate proximal to the occlusion and anastomose with vessel/s distal to the occlusion. These collateral pathways can be classified as viscero–systemic, systemic–systemic, and visceral–visceral. CT angiography (CTA) is often the initial modality for evaluating patients with atherosclerotic vascular disease, because it is non-invasive and has been shown to be comparable to conventional angiography. Most collateral pathways are well demonstrated on CTA, which therefore is a useful tool for preoperative planning and regional interventional procedures.
- 4 November 2014
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 38 (2) , 361-371
Small Versus Large-Sized Drug-Eluting Beads (DEBIRI) for the Treatment of Hepatic Colorectal Metastases: A Propensity Score Matching Analysis
To compare the feasibility, safety, and efficacy with small and large irinotecan drug-eluting beads (DEBIRI) for treating hepatic colorectal metastases.
- 4 November 2014
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 38 (2) , 361-371
Small Versus Large-Sized Drug-Eluting Beads (DEBIRI) for the Treatment of Hepatic Colorectal Metastases: A Propensity Score Matching Analysis
To compare the feasibility, safety, and efficacy with small and large irinotecan drug-eluting beads (DEBIRI) for treating hepatic colorectal metastases.
- 8 June 2013
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 36 (6) , 1719-1720
Irreversible Electroporation: Hype or Hope?
- 8 June 2013
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 36 (6) , 1719-1720
Irreversible Electroporation: Hype or Hope?